CD70 and IFN-1 selectively induce eomesodermin or T-bet and synergize to promote CD8+ T-cell responses

European Journal of Immunology

Volumn 45, Issue 12, 2015, Pages 3289-3301

  Dong, Han ^a   Franklin, Nathan A ^a   Ritchea, Shane B ^a   Yagita, Hideo ^b   Glennie, Martin J ^c   Bullock, Timothy N J ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

CD27; CD70; CD8+ T cells; IFN 1; IL 12

Indexed keywords

ALPHA INTERFERON; CD27 ANTIGEN; CD40 ANTIGEN; CD70 ANTIGEN; EOMESODERMIN; INTERFERON; INTERLEUKIN 12; OVALBUMIN; TOLL LIKE RECEPTOR 3; TRANSCRIPTION FACTOR T BET; EOMES PROTEIN, MOUSE; T BOX TRANSCRIPTION FACTOR; T-BOX TRANSCRIPTION FACTOR TBX21; TOLL LIKE RECEPTOR;

ADENOVIRIDAE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL EXPANSION; CELL PROLIFERATION; CELL STIMULATION; CYTOKINE PRODUCTION; CYTOTOXICITY; DENDRITIC CELL; EFFECTOR CELL; IMMUNIZATION; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; C57BL MOUSE; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; PHYSIOLOGY;

ANIMALS; ANTIGENS, CD70; CD8-POSITIVE T-LYMPHOCYTES; IMMUNOLOGIC MEMORY; INTERFERON TYPE I; INTERLEUKIN-12; MICE; MICE, INBRED C57BL; T-BOX DOMAIN PROTEINS; TOLL-LIKE RECEPTORS;

EID: 84952637705     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201445291     Document Type: Article

References (72)

1. van Stipdonk, M. J., Lemmens, E. E. and Schoenberger, S. P., Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat. Immunol. 2001. 2: 423-429.
2. Kaech, S. M. and Ahme, R., Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat. Immunol. 2001. 2: 415-422.
3. Joshi, N. S., Cui, W., Chandele, A., Lee, H. K., Urso, D. R., Hagman, J., Gapin, L. et al., Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity 2007. 27: 281-295.
4. Marzo, A. L., Klonowski, K. D., Le Bon, A., Borrow, P., Tough, D. F., and Lefrancois, L., Initial T cell frequency dictates memory CD8+ T cell lineage commitment. Nat. Immunol. 2005. 6: 793-799.
5. Angelosanto, J. M. and Wherry, E. J., Transcription factor regulation of CD8+ T-cell memory and exhaustion. Immunol. Rev. 2010. 236: 167-175.
6. Sarkar, S., Kalia, V., Haining, W. N., Konieczny, B. T., Subramaniam, S., and Ahmed, R., Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates. J. Exp. Med. 2008. 205: 625-640.
7. Rutishauser, R. L. and Kaech, S. M., Generating diversity: transcriptional regulation of effector and memory CD8 T-cell differentiation. Immunol. Rev. 2010. 235: 219-233.
8. Pearce, E. L. and Shen, H., Generation of CD8 T cell memory is regulated by IL-12. J. Immunol. 2007. 179: 2074-2081.
9. Wilson, D. C., Matthews, S. and Yap, G. S., IL-12 signaling drives CD8+ T cell IFN-gamma production and differentiation of KLRG1+ effector subpopulations during Toxoplasma gondii Infection. J. Immunol. 2008. 180: 5935-5945.
10. Fuertes, M. B., Kacha, A. K., Kline, J., Woo, S. R., Kranz, D. M., Murphy, K. M. and Gajewski, T. F., Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8+ dendritic cells. J. Exp. Med. 2011. 208: 2005-2016.
11. Kolumam, G. A., Thomas, S., Thompson, L. J., Sprent, J. and Murali-Krishna, K., Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J. Exp. Med. 2005. 202: 637-650.
12. Xiao, Z., Casey, K. A., Jameson, S. C., Curtsinger, J. M. and Mescher, M. F., Programming for CD8 T cell memory development requires IL-12 or type I IFN. J. Immunol. 2009. 182: 2786-2794.
13. Tesselaar, K., Gravestein, L. A., van Schijndel, G. M., Borst, J. and Van Lier, R. A., Characterization of murine CD70, the ligand of the TNF receptor family member CD27. J. Immunol. 1997. 159: 4959-4965.
14. Bullock, T. N. and Yagita, H., Induction of CD70 on dendritic cells through CD40 or TLR stimulation contributes to the development of CD8+ T cell responses in the absence of CD4+ T cells. J. Immunol. 2005. 174: 710-717.
15. Taraban, V. Y., Rowley, T. F. and Al Shamkhani, A., Cutting edge: a critical role for CD70 in CD8 T cell priming by CD40-licensed APCs. J. Immunol. 2004. 173: 6542-6546.
16. Van Deusen, K. E., Rajapakse, R. and Bullock, T. N., CD70 expression by dendritic cells plays a critical role in the immunogenicity of CD40-independent, CD4+ T cell-dependent, licensed CD8+ T cell responses. J. Leukoc. Biol. 2009. 87: 477-485.
17. Schildknecht, A., Miescher, I., Yagita, H. and Van Den, B. M., Priming of CD8+ T cell responses by pathogens typically depends on CD70-mediated interactions with dendritic cells. Eur. J. Immunol. 2007. 37: 716-728.
18. Feau, S., Garcia, Z., Arens, R., Yagita, H., Borst, J. and Schoenberger, S. P., The CD4(+) T-cell help signal is transmitted from APC to CD8(+) T-cells via CD27-CD70 interactions. Nat. Commun. 2012. 3: 948.
19. Hendriks, J., Xiao, Y. and Borst, J., CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool. J. Exp. Med. 2003. 198: 1369-1380.
20. Dolfi, D. V., Boesteanu, A. C., Petrovas, C., Xia, D., Butz, E. A. and Katsikis, P. D., Late signals from CD27 prevent Fas-dependent apoptosis of primary CD8+ T cells. J. Immunol. 2008. 180: 2912-2921.
21. Peperzak, V., Xiao, Y., Veraar, E. A. and Borst, J., CD27 sustains survival of CTLs in virus-infected nonlymphoid tissue in mice by inducing autocrine IL-2 production. J. Clin. Invest. 2010. 120: 168-178.
22. Hendriks, J., Gravestein, L. A., Tesselaar, K., Van Lier, R. A., Schumacher, T. N. and Borst, J., CD27 is required for generation and long-term maintenance of T cell immunity. Nat. Immunol. 2000. 1: 433-440.
23. Salek-Ardakani, S., Flynn, R., Arens, R., Yagita, H., Smith, G. L., Borst, J., Schoenberger, S. P. et al., The TNFR family members OX40 and CD27 link viral virulence to protective T cell vaccines in mice. J. Clin. Invest. 2011. 121: 296-307.
24. Ochsenbein, A. F., Riddell, S. R., Brown, M., Corey, L., Baerlocher, G. M., Lansdorp, P. M. and Greenberg, P. D., CD27 expression promotes long-term survival of functional effector-memory CD8+ cytotoxic T lymphocytes in HIV-infected patients. J. Exp. Med. 2004. 200: 1407-1417.
25. Munitic, I., Kuka, M., Allam, A., Scoville, J. P. and Ashwell, J. D., CD70 deficiency impairs effector CD8 T cell generation and viral clearance but is dispensable for the recall response to lymphocytic choriomeningitis virus. J. Immunol. 2013. 190: 1169-1179.
26. Hendriks, J., Xiao, Y., Rossen, J. W., van der Sluijs, K. F., Sugamura, K., Ishii, N. and Borst, J., During viral infection of the respiratory tract, CD27, 4-1BB and OX40 collectively determine formation of CD8+ memory T cells and their capacity for secondary expansion. J. Immunol. 2005. 175: 1665-1676.
27. Xiao, Y., Peperzak, V., Keller, A. M. and Borst, J., CD27 instructs CD4+ T cells to provide help for the memory CD8+ T cell response after protein immunization. J. Immunol. 2008. 181: 1071-1082.
28. Dong, H., Franklin, N. A., Roberts, D. J., Yagita, H., Glennie, M. J. and Bullock, T. N., CD27 stimulation promotes the frequency of IL-7 receptor-expressing memory precursors and prevents IL-12-mediated loss of CD8(+) T cell memory in the absence of CD4(+) T cell help. J. Immunol. 2012. 188: 3829-3838.
29. Taraban, V. Y., Rowley, T. F., Kerr, J. P., Willoughby, J. E., Johnson, P. M., Al-Shamkhani, A. and Buchan, S. L., CD27 costimulation contributes substantially to the expansion of functional memory CD8(+) T cells after peptide immunization. Eur. J. Immunol. 2013. 43: 3314-3323.
30. Sanchez, P. J., McWilliams, J. A., Haluszczak, C., Yagita, H. and Kedl, R. M., Combined TLR/CD40 stimulation mediates potent cellular immunity by regulating dendritic cell expression of CD70 in vivo. J. Immunol. 2007. 178: 1564-1572.
31. Warger, T., Osterloh, P., Rechtsteiner, G., Fassbender, M., Heib, V., Schmid, B., Schmitt, E. et al., Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses in vivo. Blood 2006. 108: 544-550.
32. Ahonen, C. L., Doxsee, C. L., McGurran, S. M., Riter, T. R., Wade, W. F., Barth, R. J., Vasilakos, J. P. et al., Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN. J. Exp. Med. 2004. 199: 775-784.
33. McWilliams, J. A., Sanchez, P. J., Haluszczak, C., Gapin, L. and Kedl, R. M., Multiple innate signaling pathways cooperate with CD40 to induce potent, CD70-dependent cellular immunity. Vaccine 2010. 28: 1468-1476.
34. Thompson, L. J., Kolumam, G. A., Thomas, S. and Murali-Krishna, K., Innate inflammatory signals induced by various pathogens differentially dictate the IFN-I dependence of CD8 T cells for clonal expansion and memory formation. J. Immunol. 2006. 177: 1746-1754.
35. Wiesel, M., Kratky, W. and Oxenius, A., Type I IFN substitutes for T cell help during viral infections. J. Immunol. 2011. 186: 754-763.
36. Le, B. A., Durand, V., Kamphuis, E., Thompson, C., Bulfone-Paus, S., Rossmann, C., Kalinke, U. et al., Direct stimulation of T cells by type I IFN enhances the CD8+ T cell response during cross-priming. J. Immunol. 2006. 176: 4682-4689.
37. Keppler, S. J., Theil, K., Vucikuja, S. and Aichele, P., Effector T-cell differentiation during viral and bacterial infections: role of direct IL-12 signals for cell fate decision of CD8(+) T cells. Eur. J. Immunol. 2009. 39: 1774-1783.
38. Keppler, S. J. and Aichele, P., Signal 3 requirement for memory CD8(+) T-cell activation is determined by the infectious pathogen. Eur. J. Immunol. 2011. 41: 3176-3186.
39. Keppler, S. J., Rosenits, K., Koegl, T., Vucikuja, S. and Aichele, P., Signal 3 cytokines as modulators of primary immune responses during infections: the interplay of type I IFN and IL-12 in CD8 T cell responses. PLoS One 2012. 7: e40865.
40. Keller, A. M., Xiao, Y., Peperzak, V., Naik, S. H. and Borst, J., Costimulatory ligand CD70 allows induction of CD8+ T cell immunity by immature dendritic cells in a vaccination setting. Blood 2009. 113: 5167-5175.
41. Keller, A. M., Schildknecht, A., Xiao, Y., Van Den, B. M. and Borst, J., Expression of costimulatory ligand CD70 on steady-state dendritic cells breaks CD8+ T cell tolerance and permits effective immunity. Immunity 2008. 29: 934-946.
42. Taraban, V. Y., Rowley, T. F., Tough, D. F. and Al Shamkhani, A., Requirement for CD70 in CD4+ Th Cell-Dependent and Innate Receptor-Mediated CD8+ T Cell Priming. J. Immunol. 2006. 177: 2969-2975.
43. Sanchez, P. J. and Kedl, R. M., An alternative signal 3: CD8(+) T cell memory independent of IL-12 and type I IFN is dependent on CD27/OX40 signaling. Vaccine 2012. 30: 1154-1161.
44. Rowley, T. F. and Al Shamkhani, A., Stimulation by soluble CD70 promotes strong primary and secondary CD8+ cytotoxic T cell responses in vivo. J. Immunol. 2004. 172: 6039-6046.
45. Ontiveros, F., Wilson, E. B. and Livingstone, A. M., Type I interferon supports primary CD8+ T-cell responses to peptide-pulsed dendritic cells in the absence of CD4+ T-cell help. Immunolgy 2011. 132: 549-558.
46. Curtsinger, J. M. and Mescher, M. F., Inflammatory cytokines as a third signal for T cell activation. Curr. Opin. Immunol. 2010. 22: 333-340.
47. Longhi, M. P., Trumpfheller, C., Idoyaga, J., Caskey, M., Matos, I., Kluger, C., Salazar, A. M. et al., Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant. J. Exp. Med. 2009. 206: 1589-1602.
48. Intlekofer, A. M., Takemoto, N., Wherry, E. J., Longworth, S. A., Northrup, J. T., Palanivel, V. R., Mullen, A. C. et al., Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. Nat. Immunol. 2005. 6: 1236-1244.
49. Agarwal, P., Raghavan, A., Nandiwada, S. L., Curtsinger, J. M., Bohjanen, P. R., Mueller, D. L. and Mescher, M. F., Gene regulation and chromatin remodeling by IL-12 and type I IFN in programming for CD8 T cell effector function and memory. J. Immunol. 2009. 183: 1695-1704.
50. van Gisbergen, K. P., Klarenbeek, P. L., Kragten, N. A., Unger, P. P., Nieuwenhuis, M. B., Wensveen, F. M., ten, B. A. et al., The costimulatory molecule CD27 maintains clonally diverse CD8(+) T cell responses of low antigen affinity to protect against viral variants. Immunity 2011. 35: 97-108.
51. Willoughby, J. E., Kerr, J. P., Rogel, A., Taraban, V. Y., Buchan, S. L., Johnson, P. W. and Al-Shamkhani, A., Differential impact of CD27 and 4-1BB costimulation on effector and memory CD8 T cell generation following peptide immunization. J. Immunol. 2014. 193: 244-251.
52. Cho, H. I. and Celis, E., Optimized peptide vaccines eliciting extensive CD8 T-cell responses with therapeutic antitumor effects. Cancer Res. 2009. 69: 9012-9019.
53. Wiesel, M., Crouse, J., Bedenikovic, G., Sutherland, A., Joller, N. and Oxenius, A., Type-I IFN drives the differentiation of short-lived effector CD8+ T cells in vivo. Eur. J. Immunol. 2012. 42: 320-329.
54. Xu, H. C., Grusdat, M., Pandyra, A. A., Polz, R., Huang, J., Sharma, P., Deenen, R. et al., Type I interferon protects antiviral CD8+ T cells from NK cell cytotoxicity. Immunity 2014. 40: 949-960.
55. Crouse, J., Bedenikovic, G., Wiesel, M., Ibberson, M., Xenarios, I., Von, L. D., Kalinke, U. et al., Type I interferons protect T cells against NK cell attack mediated by the activating receptor NCR1. Immunity 2014. 40: 961-973.
56. Curran, M. A., Geiger, T. L., Montalvo, W., Kim, M., Reiner, S. L., Al-Shamkhani, A., Sun, J. C. et al., Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin. J. Exp. Med. 2013. 210: 743-755.
57. Pearce, E. L., Mullen, A. C., Martins, G. A., Krawczyk, C. M., Hutchins, A. S., Zediak, V. P., Banica, M. et al., Control of effector CD8+ T cell function by the transcription factor Eomesodermin. Science 2003. 302: 1041-1043.
58. Pipkin, M. E., Sacks, J. A., Cruz-Guilloty, F., Lichtenheld, M. G., Bevan, M. J. and Rao, A., Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells. Immunity 2010. 32: 79-90.
59. Obar, J. J., Molloy, M. J., Jellison, E. R., Stoklasek, T. A., Zhang, W., Usherwood, E. J. and Lefrancois, L., CD4+ T cell regulation of CD25 expression controls development of short-lived effector CD8+ T cells in primary and secondary responses. Proc. Natl. Acad. Sci. U S A 2010. 107: 193-198.
60. Kalia, V., Sarkar, S., Subramaniam, S., Haining, W. N., Smith, K. A. and Ahmed, R., Prolonged interleukin-2Ralpha expression on virus-specific CD8+ T cells favors terminal-effector differentiation in vivo. Immunity 2010. 32: 91-103.
61. Starbeck-Miller, G. R., Xue, H. H. and Harty, J. T., IL-12 and type I interferon prolong the division of activated CD8 T cells by maintaining high-affinity IL-2 signaling in vivo. J. Exp. Med. 2014. 211: 105-120.
62. Arens, R., Schepers, K., Nolte, M. A., Van Oosterwijk, M. F., Van Lier, R. A., Schumacher, T. N. and van Oers, M. H., Tumor Rejection induced by CD70-mediated quantitative and qualitative effects on effector CD8+ T cell formation. J. Exp. Med. 2004. 199: 1595-1605.
63. Mumberg, D., Monach, P. A., Wanderling, S., Philip, M., Toledano, A. Y., Schreiber, R. D. and Schreiber, H., CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma. Proc. Natl. Acad. Sci. U S A 1999. 96: 8633-8638.
64. Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J. and Schreiber, R. D., IFN-gamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 2001. 410: 1107-1111.
65. Ruby, J. and Ramshaw, I., The antiviral activity of immune CD8+ T cells is dependent on interferon-gamma. Lymphokine Cytokine Res. 1991. 10: 353-358.
66. Utermohlen, O., Dangel, A., Tarnok, A. and Lehmann-Grube, F., Modulation by gamma interferon of antiviral cell-mediated immune responses in vivo. J. Virol. 1996. 70: 1521-1526.
67. Takemoto, N., Intlekofer, A. M., Northrup, J. T., Wherry, E. J. and Reiner, S. L., Cutting Edge: IL-12 inversely regulates T-bet and eomesodermin expression during pathogen-induced CD8+ T cell differentiation. J. Immunol. 2006. 177: 7515-7519.
68. Juedes, A. E., Rodrigo, E., Togher, L., Glimcher, L. H. and Von Herrath, M. G., T-bet controls autoaggressive CD8 lymphocyte responses in type 1 diabetes. J. Exp. Med. 2004. 199: 1153-1162.
69. Joshi, N. S. and Kaech, S. M., Effector CD8 T cell development: a balancing act between memory cell potential and terminal differentiation. J. Immunol. 2008. 180: 1309-1315.
70. Roberts, D. J., Franklin, N. A., Kingeter, L. M., Yagita, H., Tutt, A. L., Glennie, M. J. and Bullock, T. N., Control of established melanoma by CD27 stimulation is associated with enhanced effector function and persistence, and reduced PD-1 expression of tumor infiltrating CD8(+) T cells. J. Immunother. 2010. 33: 769-779.
71. Valenzuela, J., Schmidt, C. and Mescher, M., The roles of IL-12 in providing a third signal for clonal expansion of naive CD8 T cells. J. Immunol. 2002. 169: 6842-6849.
72. Slinker, B. K., The statistics of synergism. J. Mol. Cell. Cardiol. 1998. 30: 723-731.